Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.
Quint JK, Arnetorp S, Kocks JWH, Kupczyk M, Nuevo J, Plaza V, Cabrera C, Raherison-Semjen C, Walker B, Penz E, Gilbert I, Lugogo NL, van der Valk RJP; SABINA North American and European Study contributors.
Quint JK, et al.
J Allergy Clin Immunol Pract. 2022 Sep;10(9):2297-2309.e10. doi: 10.1016/j.jaip.2022.02.047. Epub 2022 Mar 29.
J Allergy Clin Immunol Pract. 2022.
PMID: 35364341
Free article.